Displaying 41 - 50 of 591
Image
Acute myeloid leukemia (AML): Expanding access to novel treatment and care, 2024 Leukemia Conference
Updated:
Acute myeloid leukemia (AML) is a type of cancer that forms in blood cells and bone marrow that progresses rapidly if untreated. In this presentation, Dr. Brett Houston, a hematologist at the University of Manitoba, will speak about her work in clinical trials in finding ways to…
Leukemia
Image
Acute lymphoblastic leukemia (ALL): Changing treatment goals - 2024 Leukemia Conference, LLSC
Updated:
Acute lymphoblastic leukemia (ALL) affects immature white blood cells called lymphoblasts and can progresses quickly without treatment. Dr. Dawn Maze, a member of the Leukemia Program and the Elizabeth and Tony Comper MPN Program at the Princess Margaret Cancer Centre, addresses…
Leukemia
Image
Understanding ribonucleic acid (RNA) and its role in leukemia: 2024 Leukemia Conference
Updated:
RNA is more than just DNA's lesser-known cousin. Dr. Katherine Borden, Professor, Pathology, Cell Biology at the Institute for Research in Immunology and Cancer, University of Montreal and Dr. Sarit Assouline, chief of the Division of Hematology at the JGH and Senior…
Leukemia
Image
Chronic lymphocytic leukemia (CLL): Advances in research & treatment: 2024 Leukemia Conference, LLSC
Updated:
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults and can vary from person to person. This is why a one-size-fits-all treatment approach is not optimal. Research advances in how we treat CLL are discussed by Dr. Anthea Peters, Hematologist at the…
Leukemia
Image
Chronic myeloid leukemia (CML): Treatment options, minimizing side effects, 2024 Leukemia Conference
Updated:
Chronic myeloid leukemia (CML) is a rare type of leukemia that can happen when cells that make the blood develop a genetic change called BCR-ABL1 (Philadelphia chromone). Dr. M. Lynn Savoie, hematologist at Tom Baker Cancer Centre in Calgary, Alberta, discusses treatment options…
Leukemia
The Collings Stevens Family Foundation partners with LLSC to help Canadians impacted by CML
Updated:
The Leukemia & Lymphoma Society of Canada, with partners like The Collings Stevens Family Foundation, is informing and empowering people impacted by chronic myeloid leukemia (CML), a once-fatal blood cancer now a manageable disease.
Partners, Leukemia
Image
Understanding and managing chronic myeloid leukemia (CML)
Updated:
You or your loved one has been diagnosed with chronic myeloid leukemia (CML).This booklet was designed to answer some questions you may have about chronic myeloid leukemia (CML). It summarizes what CML is and its phases, as well as treatment options available in Canada and their…
Leukemia
Show up for the blood cancer community
Updated:
Being part of Light The Night’s Executive Leadership Committee means being part of a dedicated group of volunteers who are passionate about driving revenue and awareness for Light The Night.
Why Participate in Light The Night?
Updated:
Joining Light The Night is an extraordinary opportunity to be part of something bigger than yourself.